Release Date: 25/02/10 11:59 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 66.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%